Equity · Industrials
LGN
NASDAQLegence (LGN)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for LGN to draw a line in its place.
- Revenue, year to Dec 2025
- 2.6B USD
Have Legence (LGN) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Legence insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 16 Dec 2025, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 18 Sep 2026
Buys 0Sells 2Net sold $285KOther filings 9
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Sep 2026 | Le Bris PhilippeChief Accounting Officer | Sell | 1,058 | 58K USD |
| 15 Sep 2026 | Le Bris PhilippeChief Accounting Officer | Sell | 4,196 | 227K USD |
| Sold | 2 open-market sales | 5,254 | $285K |
9 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Sep 2026 | Butz Stephen MChief Financial Officer | Tax withheld | 2,343 | 124K USD |
| 15 Sep 2026 | Le Bris PhilippeChief Accounting Officer | Option exercise | 4,196 | 117K USD |
| 15 Sep 2026 | Le Bris PhilippeChief Accounting Officer | Tax withheld | 341 | 18K USD |
| 15 Sep 2026 | Seki BryceGeneral Counsel & Secretary | Tax withheld | 653 | 35K USD |
| 15 Sep 2026 | Sprau JeffreyChief Executive Officer | Tax withheld | 9,792 | 519K USD |
| 15 Sep 2026 | Hansen Stephen DaleChief Operating Officer | Tax withheld | 1,671 | 89K USD |
| 15 Sep 2026 | Barnes GregorySee Remarks | Tax withheld | 653 | 35K USD |
| 15 Sep 2026 | Schwartz JustinChief Strategy Officer | Tax withheld | 768 | 41K USD |
| 18 Aug 2026 | Crisci RobertDirector | Award | 2,257 |
Which funds hold Legence (LGN)?
8 of the 45 institutional funds we track reported a Legence position for the quarter ended 30 Jun 2026 — a combined 296.1M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Two Sigma Investments | Added | 1,478,072 | 126.0M USD | +2,074.4% |
| Renaissance Technologies | Added | 1,180,400 | 100.6M USD | +103.6% |
| Soros Fund Management | Added | 328,000 | 28.0M USD | +147.3% |
| Marshall Wace | Added | 237,700 | 20.3M USD | +224.9% |
| Millennium Management | Added | 231,670 | 19.7M USD | +761.8% |
| Citadel Advisors | Trimmed | 9,798 | 835K USD | −88.9% |
| AQR Capital Management | New position | 6,387 | 544K USD | |
| Man Group | New position | 2,379 | 203K USD | |
| Balyasny Asset Management | Exited |
Have members of Congress traded Legence (LGN)?
The most recent congressional trade disclosed in Legence is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 03 Mar 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 03 Mar 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 35 days |
| 24 Nov 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 21 days |
What has been filed or recorded for Legence (LGN)?
The filings we hold for Legence, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 29 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 58 shares | 3K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.37 USD | Revenue $1.26B |
| 30 Jun 2026 | Financials | Total assets | 3.7B USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 600.5M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.13 USD | Revenue $1.04B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.57 USD | Revenue $2.55B |
| 31 Dec 2025 | Financials | Revenue | 2.6B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −59.8M USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.02 USD | Revenue $708M |
| 30 Jun 2025 | Quarterly earnings | Q2 2026 reported | Revenue $599M | |
| 31 Mar 2025 | Quarterly earnings | Q1 2026 reported | Revenue $506M | |
| 31 Dec 2024 | Annual report | FY 2025 reported | Revenue $2.10B | |
| 30 Sep 2024 | Quarterly earnings | Q3 2025 reported | Revenue $561M |
Legence (LGN): frequently asked questions
What is Legence’s revenue?
Legence reported revenue of 2.6B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Legence insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Legence insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 16 Dec 2025, show no open-market purchase. A further 9 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Legence?
8 of the 45 funds we track reported a Legence position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, Renaissance Technologies and Soros Fund Management. See Funds
Have members of Congress traded Legence?
Yes. 2 trades in Legence appear in the congressional disclosures we hold; the latest is a purchase by Gilbert Ray Cisneros, Jr. (House, CA) dated 3 Mar 2026, filed 7 Apr 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Legence last report earnings?
Legence last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.37 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates